Scientists challenge bioelectromagnetics foundations
Abstract
The International Commission for ElectromagneticSafety (ICEMS) was founded in February,
2003 to promote “research to protect public health
from electromagnetic fields and to develop the
scientific basis and strategies for assessment,
prevention, management and communications of
risk, based on the precautionary principle”. The
ICEMS scientists share a common understanding,
based on their combined research experience
in bioelectromagnetics, that “biological
effects can occur from exposures to both
extremely low frequency fields (ELF EMF) and
radiofrequency fields (RF EMF)” and at low
intensity exposure levels. Several international
scientific meetings have been held from 2002 to
2008. ICEMS convened the programmes through
the sponsorship of the Cities of Venice and
Benevento, University Ca’ Foscari and the
Ukrainian Academy of Science. While recognizing
the significant contribution made by the
BioInitiative Report in August 2007, this report
does not include many important studies,
including the scientific developments reported by
Del Giudice and Fleishman, Talpo, De Ninno,
Mengoli, Pazur, Grimaldi, Zhadin and Giuliani
on the possibility of effects on cells by weak
magnetic fields, which have been debated since
1992, as well as studies on alteration in cell
differentiation induced by EMF, by Grimaldi,
Lisi and others, and, the scientific information on
the mechanisms concerning EMF biointeraction.
Therefore, ICEMS will be making these contributions
to the scientific debates, in support of
biologically based exposure standards for the
general public and workers.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.